Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Vaxart Stock Is Being Squeezed At The End Of A Pattern
01:48pm, Thursday, 18'th Nov 2021
Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Thursday after bouncing off support. There looks to be no company evident news to explain the jump in price.
Zacks: Brokerages Anticipate Vaxart, Inc. (NASDAQ:VXRT) Will Announce Quarterly Sales of $860,000.00
07:18pm, Wednesday, 17'th Nov 2021 Transcript Daily
Equities analysts expect that Vaxart, Inc. (NASDAQ:VXRT) will post sales of $860,000.00 for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Vaxarts earnings. The lowest sales estimate is $200,000.00 and the highest is $2.70 million. Vaxart reported sales of $360,000.00 in the same quarter last year, which indicates a positive []
Complete data from Vaxart oral COVID-19 vaccine study in hamsters published
06:29pm, Wednesday, 17'th Nov 2021 Seeking Alpha
Vaxart: Differentiated Covid Oral Route Remains Viable
09:19pm, Tuesday, 16'th Nov 2021 Seeking AlphaVaxart: Differentiated Covid Oral Route Remains Viable
04:19pm, Tuesday, 16'th Nov 2021
In an environment where injection-type vaccines are proving to offer somewhat reduced protection against the delta variant, the risks of being infected and transmitting the virus to others remain high
Vaxart, Inc. (NASDAQ:VXRT) Shares Acquired by Northern Trust Corp
09:22am, Monday, 15'th Nov 2021 Transcript Daily
Northern Trust Corp lifted its stake in Vaxart, Inc. (NASDAQ:VXRT) by 66.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,230,345 shares of the biotechnology companys stock after purchasing an additional 493,135 shares during the quarter. Northern Trust Corps holdings in Vaxart []
Vaxart to Participate at Upcoming Conferences
04:01pm, Thursday, 11'th Nov 2021
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Andrei Floroiu, President and CEO, Dr. Sean Tucker, SVP and Chief Scientific Officer, an
VAXART, INC. (VXRT) Reports Q3 Loss, Lags Revenue Estimates
07:04pm, Thursday, 04'th Nov 2021
VAXART, INC. (VXRT) delivered earnings and revenue surprises of 6.67% and -9.91%, respectively, for the quarter ended September 2021.
Don't Write Off Vaxart, As Its Oral Vaccine Still Has a Chance
11:29am, Wednesday, 20'th Oct 2021
VXRT stock is still worth a shot, as there's still big potential demand for a "no-needle" Covid-19 vaccine alternative. The post Don't Write Off Vaxart, As Its Oral Vaccine Still Has a Chance appeared
Can This COVID Vaccine Stock Help Make You Rich?
11:30am, Saturday, 16'th Oct 2021
This biotech has a nifty trick potentially up its sleeve.
Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up
02:10pm, Tuesday, 12'th Oct 2021
Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesday after the Indian government approved Bharat Biotech's COVID-19 vaccine Covaxin, for children between the ages of 2 and 18. Ocugen is partn
Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?
06:00am, Sunday, 10'th Oct 2021
The company is working on a vaccine candidate that doesn't involve a needle.
VXRT Stock: Why It Saw An Increase This Week
11:31am, Saturday, 09'th Oct 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) increased by over 8% between Monday morning and Friday morning. This is why it happened.
Why Vaxart Shares Are Trading Higher Today
09:57am, Friday, 08'th Oct 2021
Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational oral tablet vaccine reduced th
These 2 COVID-19 Stocks Could Boost the Market Friday
07:16pm, Thursday, 07'th Oct 2021
Thursday's gains could be just the beginning.
